Bronchial inflammation in corticosteroid-sensitive and corticosteroid-resistant asthma at baseline and on oral corticosteroid treatment

Clinical and Experimental Allergy

Volumn 32, Issue 4, 2002, Pages 578-582

  Chakir, J ^a,c   Hamid, Q ^b   Bosse M ^a   Boulet, L P ^a   Laviolette, M ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Airway inflammation; Asthma; Bronchial biopsies; Corticosteroid; Corticosteroid resistance

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CD3 ANTIGEN; CD68 ANTIGEN; CORTICOSTEROID; INTERLEUKIN 2 RECEPTOR; LEUKOCYTE ELASTASE; MALTOSE BINDING PROTEIN; METHYLPREDNISOLONE; TRYPTASE;

ADULT; ARTICLE; ASTHMA; BRONCHITIS; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CELL COUNT; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LYMPHOCYTE COUNT; MALE; NEUTROPHIL; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ADRENERGIC BETA-AGONISTS; ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHI; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; MALE; METHYLPREDNISOLONE; RECEPTORS, ADRENERGIC, BETA-2; RESPIRATORY MUCOSA;

EID: 0036227346     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0954-7894.2002.01323.x     Document Type: Article

References (22)

1. Mucosal inflammation in asthma
2. Corticosteroids in the treatment of asthma
3. Novel mechanisms of glucocorticoid-mediated gene repression: Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin-8 gene expression
4. Cytokines in the lung
5. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma
6. Prednisolone treatment in asthma: Reduction in the number of eosinophils, T cells, tryptaseonly positive mast cells, and modulation of IL-4, IL-5 and interferon-gamma cytokine gene expression within the bronchial mucosa
7. Steroid-resistant asthma: Cellular mechanisms contributing to inadequate response to glucocorticoid therapy
8. Differential in vitro regulation by glucocorticoids of monocytederived cytokine generation in glucocorticoid-resistant bronchial asthma
9. Glucocorticoid resistance in chronic asthma: Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro
10. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroidresistant asthma
11. Glucocorticoid receptor localization in normal and asthmatic lung
12. Dysregulation of interleukin 4, interleukin 5, and interferon-gamma gene expression in steroid-resistant asthma
13. Combination of IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T-cell responses to glucocorticoid
14. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
15. Effect of salmeterol on allergen-induced airway inflammation in mild allergic asthma
16. Immuno-histochemistry on resin sections: A comparison of resin embedding. Technique for a small mucosal biopsies
17. Lower airways remodelling in non-asthmatic subjects with allergic rhinitis
18. Eosinophils, T-lymphocytes, mast-cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness
19. Role of mast cells and basophils in asthma
20. Mast cells in asthma
21. Airways remodeling is a distinctive feature of asthma and is related to severity of disease
22. Serum matrix metalloproteinase-9: Tissue inhibitor of metalloproteinase-1 ratio correlates with steroid responsiveness in moderate to severe asthma